This year, our team submitted some new experimental data to existing bio bricks, which will be useful tools for other iGEM teams in the future.
1.1Construction
We have constructed a composite part (BBa_K5248053) utilizing KpsE (BBa_K5248007) and KpsT (BBa_K5248008) (see Figures 1 and 2).
1.2 Validation
We have successfully transformed the aforementioned plasmids into our chassis strain, Escherichia coli Nissle 1917 (DE3), and conducted quantitative polymerase chain reaction (qPCR) to verify the expression levels of the target genes. The results indicate a substantial overexpression of mRNA for both KpsE and KpsT genes.
Additionally, we performed the extraction and quantification of bacterial capsular polysaccharides from the engineered strain, using the strain transformed with an empty vector as a control. As depicted in Figure 5, the KpsE-KpsT genetically engineered strain showed a significant increase in capsular polysaccharide production compared to the strain with the empty vector. All these findings may be of assistance to other teams. We hope that this work will contribute to the iGEM community.
2.1 Construct
We have constructed a composite part, pETduet-1-mcmI-2(6his)-mcmA(strep) (BBa_K5248058), on the pETduet-1 vector backbone (see Figures 1 and 3).
Furthermore, we have also constructed another composite part, pACYCDuet-1-mCherry-mchI(6his)-EGFP-mchB(strep) (BBa_K5248055), on the pACYCDuet-1 vector backbone (see Figures 2 and 4).
2.2 Verify
Regarding antimicrobial peptides, we have completed the experimental characterization of two parts (BBa_K5248058 and BBa_K5248055) and have added the new data to their respective BioBrick entries.
BioBricks | Plasmid name | Characterization Method |
---|---|---|
BBa_K5248058 | pETduet-1-mcmI-2(6his)-mcmA(strep) | Antibacterial zone assay |
BBa_K5248055 | pACYCDuet-1-mCherry-mchI(6his)-EGFP-mchB(strep) | Antibacterial zone assay |
Antibacterial zone assay:
The results indicate that the strains harboring the designed plasmids for mcmA or mchB expression exhibit visible zones of inhibition, capable of protecting the host cells from the antimicrobial peptides they produce. Further use and characterization of these two antimicrobial peptides in our project can be found on our Engineering Success and Results pag.